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Objectives. The purpose of bowel cancer screening is to test for signs of cancer before
symptoms develop. Financial incentives are one potential method to increase participa-
tion rates. Few studies have tested incentives in relation to bowel screening in the United
Kingdom (UK). The current research explored reactions to different financial incentives
to participate in population-level bowel cancer screening in a UK sample.
Design. An online mixed methods study. Recruitment was via a study recruitment
website (https://prolific.ac/).
Methods. 499 participants (aged 60–74 years) completed a survey on invitations for
population-level bowel cancer screening using different levels of financial incentives.
Result. Respondents were generally positive about the use of financial incentives. A £10
voucher wasmost frequently selected as the appropriate amount to incentivise screening
participation. The current invitation method with no voucher was judged to be most
acceptable but suggested to produce the lowest likelihood of others participating.
Offering a £10 voucher that theNHSwould not be charged for if not used was the second
most acceptable invitation method. There were few differences between invitation
methods on own perceived likelihood of participation in bowel screening. Offering a £10
voucher was seen as leading to the greatest likelihood of others participating in bowel
screening. Findings were largely unaffected by participant demographics.
Conclusion. The use of small financial incentives to increase bowel cancer screening
uptake was generally well received. Impacts of incentives on actual bowel screening rates
in UK samples need to be established in the light of the current findings.
Statement of contribution
What is already known on this subject?
 Bowel cancer screening uptake in theUK is suboptimal, particularly in specific groups of the population
including men and individuals from more deprived areas.
 Financial incentives have been suggested as one means to increase participation rates.
 Few studies have evaluated the acceptability of incentives in relation to bowel screening in the UK.
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What does this study add?
 Respondents were generally positive about the use of financial incentives to increase screening uptake.
 A £10 voucher was most frequently selected as the appropriate amount to incentivise uptake.
 Interventions involving incentives were perceived to increase other’s but not own participation.
Background
Cancer screening aims to check the body for cancer before any symptoms develop. This
can help to diagnose and treat cancer at an early stage (Cancer Research UK, 2021) and
contribute to reducing overall mortality. Bowel cancer is the fourthmost common cancer
in the United Kingdom, every year 42,000 people are diagnosed, and more than 16,000
people die from bowel cancer (Cancer Research UK, 2021). Early identification of bowel
cancer could prevent a large number of deaths (Cancer Research UK, 2021). In the United
Kingdom, individuals over 60 are invited to the routine bowel cancer screening every two
years, but around 30–40% of people do not take part in screening. Screening in all UK
nations now uses the Faecal Immunochemical Test (FIT), which requires individuals to
provide a stool sample which is tested for traces of blood. Introduction of the FIT to
Scotland in 2017 resulted in an increase in screening rates, although these have remained
suboptimal in deprived populations (Public Health Scotland, 2021).While screening rates
are above what is considered the ‘acceptable threshold’ (52% uptake) for screening,
uptake varies across the UKnations. Research is therefore needed on howbest to increase
bowel screening rates in the United Kingdom, particularly in groups with low
participation rates such as men and individuals from more deprived areas (Cancer
Research UK, 2021). The aims of this research were to investigate the use of financial
incentives to promote screening rates. In particular, the research focussed onperceptions
of different types of financial incentives to inform the design of future interventions.
The effectiveness of financial incentives has been tested in a range of different health
behaviours (Adams, Giles, McColl, & Sniehotta, 2014) and is suggested to incorporate a
range of behaviour change techniques, including goal setting, behaviouralmonitoring and
rewarding behaviour (Johnston&Sniehotta, 2010). Incentives provide short-term, certain
rewards associated with the performance of a health behaviour, where usually any gain
associated with the behaviour is uncertain and occurs in the future. It has also been
suggested that incentives are most effective in relation to simple, discrete, time-limited
health behaviours (Lynagh, Sanson-Fisher, & Bonevski, 2013). Bowel cancer screening
incorporates all three of these aspects of behaviour. Despite this, a recent review of
interventions to promote bowel screening (Tsipa et al., 2020) identified over 100
randomised controlled trials (RCTs) and reported that incentives were one of the least
commonly used behaviour change techniques.
A systematic review byMauro, Rotundo, and Giancotti (2019) reported little evidence
for using financial incentives to improve breast or cervical screening rates but
demonstrated some promising evidence in relation to increasing bowel screening, whilst
noting the need for further research. Three recent RCTs from the United States reported a
number of promising, but not always statistically significant, findings. Green et al. (2019)
compared the effects of mailing an incentive ($10) following screening completion to
being entered into a lottery (1 in 10 chance towin $50) and a control condition. This study
found both interventions to significantly increase uptake compared to the control
condition (incentive: 76.7%; lottery: 74.6%; control: 71.5% screening uptake) with the
incentive condition yielding the largest effect. Other studies have demonstrated the
benefits of a $10 incentive compared to no incentive (Lieberman et al., 2019; Mehta et al.,
2 Sarah Wilding et al.
2019). However, not all evidence supports a positive impact of incentives on bowel
cancer screening. Gupta et al. (2016) found no effect of either a $5 or $10 incentive in a
sample not up-to-date with their screening.
No published studies have investigated the influence of providing incentives to
increase bowel cancer screening uptake in the United Kingdom. There have, however,
been systematic reviews of financial incentives on smoking cessation (Giles, Robalino,
McColl, Sniehotta, & Adams, 2014), and physical activity (Mitchell et al., 2020). These
studies tended to report positive findings for the use of incentives. However, theremay be
some negative effects of providing incentives. One study in non-attenders to diabetic eye
screening found that individuals offered a lottery incentive and fixed cash incentive were
less likely to attend screening compared to usual care control (Judah et al., 2018).
Acceptability is a key requirement for successful behaviour change interventions
(Moore et al., 2015; Sekhon, Cartwright, & Francis, 2017), this can include affective
reactions to the intervention as well as its perceived effectiveness. It may not be
considered morally or ethically appropriate to offer monetary incentives to encourage
health behaviours (Lynagh et al., 2013). Previouswork looking at the impact of incentives
on bowel cancer screening has focussed only on their effectiveness to encourage uptake.
It is therefore important to understand individuals’ perceptions of the acceptability of
incentives in this specific behaviour. This research was designed to increase our
understanding of reactions towards the use of different financial incentives to promote
bowel screening in the United Kingdom and inform the design of an RCT to test the
effectiveness of such an intervention on screening rates. The research aimed, first, to
assess the perceived acceptability to the use of incentives to promote bowel screening in
the United Kingdom and explore how these vary by gender, age group, socio-economic
status (SES) group and recency of screening. Second, to assess reactions to specified
incentives that varied in the monetary value (based on previous research we focussed on
£5 and £10 unconditional incentives) and what happened to any unconditional incentive
if participants choose not to use it (i.e., not specified, NHS not charged if not used, unused
vouchers could be returned to the NHS) compared to no incentive control. We also
explored how these responses varied by gender, age group, SES group and recency of
screening.
To summarise, our two main research questions were:
1. Are financial incentives for bowel screening acceptable to individuals living in the
United Kingdom?
2. What are individuals’ reactions to different levels of financial incentives for bowel
screening and do these differ by demographic groups?
Method
Sample
A total of 499 respondents who would all be eligible for bowel screening based on their
age (≥60 years), were recruited in May 2021 via Prolific (https://prolific.ac/), an online
research recruitment website. All individuals were living in the United Kingdom and each
of the four UK nations was represented. The respondents were recruited to ensure
roughly equal numbers of men and women (249 women, 250 men) and under and over
65 years of age (250 aged ≤65; 249 aged> 65;Mean= 65.6, SD= 3.97). The vastmajority of
the sample were white (N = 488, 97.8%; non-white N = 11, 2.2%), precluding detailed
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analysis of differences by ethnicity. Based on self-reported post-code, an Index ofMultiple
Deprivation (IMD) decile was calculated using the post-code lookup provided by each of
the UK nations (Ministry of Housing, Communities, & Local Government, 2021; Northern
Ireland Statistics & Research Agency, 2021; Scottish Government, 2021; Welsh Govern-
ment, 2021) and 244 (48.9%) respondents were coded into the lower five deciles (most
deprived SES group) and 255 (51.1%) into the upper five deciles (least deprived SES
group). Themajority of participantswere up-to-datewith their screening (up-to-date: past
two years,N = 315, 63.1%; (overdue: longer than past two years/never,N = 184, 36.9%).
The sample size was selected to have sufficient power (>90%) to detect small sized
differences between different financial incentives in different groupings (i.e., gender, age,
SES or recency of screening groups) with alpha = .05.
Measures
The main online questionnaire consisted of four sections (outlined in detail below): (1)
Background information, (2) Open-ended questions on views about financial incentives,
(3) Questions on acceptability and uptake on financial incentives, and (4) Questions on
the usefulness and appropriate value of incentives.
1. Respondents completed measures to capture demographic information including
gender, age, ethnicity, and postcode (which was converted into IMD). They also
reported when they last took part in bowel cancer screening.
2. Respondents then completed open-ended questions on their views of different
incentives for participating in bowel screening and what might make this more
acceptable (‘What are your views on offering a £5 or £10 voucher to encourage
participation in bowel screening?’; ‘Whatmight make offering a £5 or £10 voucher to
encourage participation in bowel screening more acceptable?’).
3. Respondentswere presentedwith seven differentmethods of being invited for bowel
cancer screening (details below, see Table 1 for the invitation text presented to
participants). Participants were asked to complete four questions on each invitation.
The order in which the questions were asked remained the same but the order in
which the different invitations were presented was randomised. The first two
questions asked about how happy they would be invited in this way (‘I would be
happy to be invited to participate in bowel screening in this way’, strongly agree,
agree, somewhat agree, neither agree nor disagree, somewhat disagree, disagree,
strongly disagree; scored 7-1) and how acceptable it would be to invite everyone in
this way (‘This is an acceptable way to invite everyone to participate in bowel
screening’, strongly agree, agree, somewhat agree, neither agree nor disagree,
somewhat disagree, disagree, strongly disagree; scored 7-1). The second two
questions asked about how likely they (likely (self); ‘How likely would you be to use
and return a bowel screening kit if invited in this way?’, extremely likely, moderately
likely, slightly likely, neither likely nor unlikely, slightly unlikely, moderately likely,
extremely likely; scored 7-1) and others (likely (others); ‘How likely do you think
most people would be to use and return a bowel screening kit if invited in this way’,
extremely likely, moderately likely, slightly likely, neither likely nor unlikely, slightly
unlikely, moderately likely, extremely likely; scored 7-1) would be to use and return a
bowel screening kit if invited in this way.
4. Finally, four questions focussed on general thoughts on using financial incentives to
promote bowel screening. Respondents rated how useful research on this topic
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might be (‘Running a research study to test if using small financial incentives
increases bowel cancer screening is a good idea’, strongly agree, agree, somewhat
agree, neither agree nor disagree, somewhat disagree, disagree, strongly disagree;
scored 7-1), the extent to which incentives in general might be useful (‘Using small
financial incentives to help increase bowel cancer screening is a good idea’, strongly
agree, agree, somewhat agree, neither agree nor disagree, somewhat disagree,
disagree, strongly disagree; scored 7-1), and the most appropriate value for such
incentives (‘What do you think would be the right voucher value to offer to help
increase bowel cancer screening?, £0, £5, £10, £20, £30, £40, £50, Other – specify
amount; scored 0, 1, and 2 for the first three responses and 3 for all other responses).
Finally, an open-ended question requested any further thoughts (‘If you have any
further thoughts on using small financial incentives to increase bowel cancer
screening, please write them here’).
Procedure and invitations
Respondentswere recruited via Prolific (https://prolific.ac/) andwere invited to take part
in a ‘cancer screening survey’. They gave informed consent and were then asked to
complete the questionnaire via Qualtrics. On completion they were thanked and paid
£1.25 for completing a 15-min survey.
Table 1. The seven invitations presented to participants
Invitation 1 You are sent a standard written invitation to participate in bowel cancer screening plus a
bowel cancer screening test to use and return
Invitation 2 You are sent a standard written invitation to participate in bowel cancer screening plus a
bowel cancer screening test to use and return. You’ll also receive a £5 voucher (e.g., high
street voucher or Amazon voucher) to encourage you to use and return the kit
Invitation 3 You are sent a standard written invitation to participate in bowel cancer screening plus a
bowel cancer screening test to use and return. You’ll also receive a £10 voucher (e.g., high
street voucher or Amazon voucher) to encourage you to use and return the kit
Invitation 4 You are sent a standard written invitation to participate in bowel cancer screening plus a
bowel cancer screening test to use and return. You’ll also receive a £5 voucher (e.g., high
street voucher or Amazon voucher) to encourage you to use and return the kit. If you
decide not to spend the voucher, then the NHS will not be charged
Invitation 5 You are sent a standard written invitation to participate in bowel cancer screening plus a
bowel cancer screening test to use and return. You’ll also receive a £10 voucher (e.g., high
street voucher or Amazon voucher) to encourage you to use and return the kit. If you
decide not to spend the voucher, then the NHS will not be charged
Invitation 6 You are sent a standard written invitation to participate in bowel cancer screening plus a
bowel cancer screening test to use and return. You’ll also receive a £5 voucher (e.g., high
street voucher or Amazon voucher) to encourage you to use and return the kit. You can
choose to send the unused voucher to a provided address to ensure that the NHSwill not
be charged
Invitation 7 You are sent a standard written invitation to participate in bowel cancer screening plus a
bowel cancer screening test to use and return. You’ll also receive a £10 voucher (e.g., high
street voucher or Amazon voucher) to encourage you to use and return the kit. You can
choose to send the unused voucher to a provided address to ensure that the NHSwill not
be charged
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Respondents were presented with seven invitations designed to examine different
levels of reward voucher to encourage use of the bowel screening test kit (£0, £5, £10) and
specifications ofwhat happened to unused reward vouchers (i.e., unconditional incentive
sent with the FIT). The order of presentation of these invitations was randomised. The
seven invitations are reported in Table 1.
Ethical approval
Approval was granted by the University of Leeds, School of Psychology Ethics Committee
(Ref: PSYC-264, Date: 11/05/2021). All participants provided informed consent prior to
completing the online survey.
Analyses
Wefirst content coded the three open-ended questions on general views of using financial
incentives to encourage participation in bowel screening. Following the steps outlined by
Elo and Kyng€as (2008), responses were read to ensure familiarity with thematerial and its
context. Comments were coded by identifying recurring words or units of meaning and
frequency of reporting each of these codes was calculated. Codes were grouped into
categories and reread and compared to check for consistency of meaning based on the
context of the comments. The frequency of reporting of these categories was calculated.
A random 10% were double coded by a second reviewer and disagreements resolved by
discussion. Chi-squared tests were used to test for differences in the coded responses by
gender, age group, SES group and recency of bowel screening participation. Responses to
the first open-ended question, requesting participant views on offering a financial
incentive to encourage bowel cancer screening uptake, were coded as positive, negative,
neutral, or mixed. The second open-ended question asked participants to report their
views on how offering an incentive might be made more acceptable. The responses were
coded into charity donation, voucher characteristics, saving the NHS money, advertising
or other (not further analysed here).
Second, we examined responses to the three overall views questions and used
between-subjects ANOVA to examine any differences by gender (male; female), age group
(<65 years; >65 years), SES group (higher deprivation; lower deprivation) and recency of
bowel screening participation (up-to-date: screened in past 2 years; overdue: screened
more than 2 years ago/never screened). Third, we examined responses to the four
questions about each of the seven invitations using a series of mixed ANOVAs to examine
any differences by invitation (within-subject factor), gender, age group, SES group, and
recency of bowel screening participation (between-subjects factors). The ANOVA
focussed onmain effects and 2-way interactions between invitations andother variables to
avoid problems with small cell sizes and to be consistent with our power calculations.
Quantitative analyses were performed in SPSS v.27. Any differences between invitations
were assessed using post-hoc Bonferroni tests.
Results
Views on offering a financial incentive to encourage bowel cancer screening uptake
There was an 82% rate of agreement with the second reviewer in this coding. Overall,
40.7% (N = 203) of responses to this question were positive. The most commonly
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reported positive viewswere that offering incentiveswas ‘a good idea’ and that itmay save
the NHSmoney in the long run by reducing future treatment costs (e.g., ‘A good thing if it
makes the difference between somebody completing the test, or not. It might even save
the NHS money by reducing the number of expensive major interventions’). Several
participants also reported that the incentives would be particularly welcome in the
‘current climate’, we interpreted this as referring to the current COVID-19 pandemic
where people may be struggling financially. Additional quotes for each question, along
with demographic information on the respondents are provided in Table S1.
A smaller proportion of responses were negative (34.7%; N = 173). Participants with
negative views tended to report that it should not be necessary to provide people with
incentives to encourage screening, while other participants reported that they did not
think that providing incentives would be effective in increasing uptake (e.g., ‘I do not
think it would help’). Finally, participants also reported that they considered screening to
be a personal responsibility (e.g., ‘I think it’s sad that some people need to be bribed to do
something for the sake of their own health’).
There were also a number of mixed or neutral (24.6%; N = 123) viewpoints shared.
These opinions seemed to reflect that a number of participants felt thatwhile it should not
be necessary for people to require incentives to complete the screening, incentiveswould
likely increase uptake and thiswas considered to be a good thing.While someparticipants
also reported that while they personally would not need the incentive to carry out
screening, it might influence others (e.g., ‘Mixed feelings. I strongly feel that people
should make the effort to look after their own health but am also aware of the financial
burden on the NHS of those who do not’).
The coding of the 499 responses to this question did not differ by participant gender,
age, or deprivation (ps > .40). However, there were differences when comparing up-to-
date versus overdue/never screened respondents. A greater proportion of respondents
who were not up to date with their screening reported positive views to offering
incentives (52.4%; N = 43/82) compared to up-to-date participants (37.2%; N = 123/
331). However, similar proportions of both groups reported negative views (not up-to-
date:N = 28/82, 34.1%; up-to-date:N = 117/331, 35.3%) and the key difference between
these groups appeared to be that more of the up-to-date participants reported mixed
views (N = 65/331, 19.6%; not up-to-date: N = 7/82, 8.5%). This difference is likely to be
due to more up-to-date participants reporting that while they personally would not need
the incentive, it might work with other individuals.
Views on how offering an incentive might be made more acceptable
There was a 96% rate of agreement with the second reviewer in this coding. Of the 499
responses to this question, the most commonly reported responses to this were if the
voucher could be donated to charity or back to the NHS (N = 49, 9.8%; e.g., ‘I would like
themoney to go back to an NHS charity’; ‘That the voucher were for a donation to various
cancer charities’) and if the voucher was easy to use and flexible (N = 47, 9.4%; e.g., ‘A
useful voucher (either general or flexible so could beused lots of places) and long expiry’).
Participants also reported if providing the incentive was cost-effective for the NHS it
wouldmake the incentive more acceptable (N = 25, 5.0%; e.g., ‘If it could be shown to be
cost effective for the NHS’; ‘It would hopefully catch bowel cancer early therefore saving
money by not having to spend more money for treatment if it is more advanced’). Finally,
some participants also reported that it would be worthwhile advertising the incentive to
explain why it was being offered (N = 47, 9.4%; e.g., ‘If it was widely known that it was
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available as an incentive, maybe publicity’; ‘An ad campaign explaining the decision’). Chi
square analyses demonstrated that the proportion of participants reporting these four
most commonly reported responses to this item (i.e., charity; voucher characteristics;
saving the NHSmoney, and advertising) did not significantly differ by age, past behaviour,
gender, or deprivation (p > .44).
The final open-ended question asked for any further thoughts on providing incentives
to increase bowel cancer screening. The 272 responses to this question varied, with some
participants using this as an opportunity to restate the point that the incentive should
optionally be returned to charity (N = 10, 3.6%; e.g., ‘It would be good if the voucher
could also be sent to a cancer charity as an alternative’), a number of comments (N = 55,
20.2%) reported the belief that the incentive should only be received once the screening
test was returned (a conditional incentive; e.g., ‘I think the money voucher should be
given after the kit has been completed and returned rather than given at same time as kit.
Some people might spend the voucher but not use and return the kit.’).
Overall views on using financial incentives
Most respondents thought conducting research on incentives was a good idea (M = 5.89,
SD = 1.34) with 86.8% (N = 433/499) indicating they ‘strongly agree’, ‘agree’, or
‘somewhat agree’ with this statement. There were no differences by gender, F(1,
483) = 0.19, p = .663, age group, F(1, 483) = 0.42, p = .520) or SES, F(1, 483) = 1.08,
p = .300, although there was by recency of bowel screening participation, F(1,
483) = 3.99, p = .046. Those who were up-to-date with screening (M = 5.73, SE =
.100) were less positive about research on incentives compared to those who were
overdue/never screened (M = 5.98, SE = .076). A smaller majority agreed that using
incentives to promote bowel screening was a good idea (M = 4.62, SD = 1.89) with 310
(62.1%) indicating they ‘strongly agree’, ‘agree’, or ‘somewhat agree’ with this statement.
There were no differences by gender, F(1, 483) = 0.34, p = .562, age group, F(1, 483) =
0.39, p = .530 or recency of bowel screening participation, F(1, 483) = 1.00, p = .318,
although there were significant differences by SES, F(1, 483) = 4.81, p = .029. Those who
were least deprived (M = 4.40, SE = .128) were less positive about research on incentives
compared to those who were most deprived (M = 4.78, SE = .121). Finally, most
respondents (N = 433, 86.8%) selected the three smallest amounts as the most
appropriate amount for an incentive (£0, N = 119, 23.8%; £5, N = 108, 21.6%; £10,
N = 206, 41.3%). There were no differences by gender, F(1, 483) = 3.72, p = .054, age
group, F(1, 483) = 0.27, p = .607, or SES, F(1, 483) = 1.10, p = .294, although there was by
recency of bowel screening participation, F(1, 483) = 4.62, p = .032. Those whowere up-
to-date (M = 1.31, SE = .074) selected lower incentives compared to those who were
overdue/never screened (M = 1.51, SE = .056).
Reactions to different financial incentives
Regarding respondents’ happiness to be invited to bowel screening in different invitation
conditions, there were significant effects of invitation, F(6, 2,964) = 42.60, p < .001, but
not gender, F(1, 494) = 1.56, p = .212, age group, F(1, 494) = 0.00, p = .991, SES, F(1,
494) = 3.18, p = .075, or recency of bowel screening participation, F(1, 494) = 2.48, p =
.116. There was also one significant two-way interaction between invitation and recency,
F(6, 2,964) = 6.25, p < .001. Table 2 (left-hand panel) shows the marginal means and
(standard errors) SEs for each invitation split by bowel screening recency. In those
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recently screened, the current invitation methodwith no incentive (i.e., invitation 1) was
most preferred. Post-hoc Bonferroni tests indicated that invitation 1 was rated more
positively than each of the other invitations that did not significantly differ from one
another. In those not recently screened, the current invitation method with no incentive
(i.e., invitation 1) was again most preferred, although the differences compared to other
invitations was attenuated (but remained significant in each case). Post-hoc Bonferroni
tests also indicated that invitation 5 (£10 voucher with NHS not charged if voucher not
used) was the secondmost preferred. It was significantly less preferred to invitation 1 but
significantly more preferred to invitations 2 and 3 plus invitations 6 and 7 (no difference
with invitation 4).
In relation to the perceived acceptability for others to be invited to bowel screening in
different invitations, there were significant effects of invitation, F(6, 2,964) = 143.94, p <
.001, but not gender, F(1, 494) = 0.00, p= .970, age group, F(1, 494) = 0.14, p = .708, SES, F
(1, 494) = 2.14, p = .144, or recency of bowel screening participation, F(1, 494) = 0.90, p =
.343. There was also one significant two-way interaction between invitation and recency,
F(6, 2,964) = 4.42, p < .001. Table 2 (right-hand panel) shows themarginal means and SEs
for each invitation split by bowel screening recency. In those recently screened, the
current invitation method with no incentive (i.e., invitation 1) was perceived to be most
acceptable to others. Post-hoc Bonferroni tests indicated that this invitation was rated
significantly more positively than each of the other invitations. They also indicated that
invitation 5 was perceived to be significantly more acceptable to others compared to
invitation 3. No other differences between invitations were statistically significant. In
those overdue/never screened, the current invitation method (i.e., invitation 1) with no
incentive was again judged to be most acceptable, although the differences compared to
other invitations was attenuated (but remained significant in each case). Post-hoc
Bonferroni tests also indicated that invitations 4 and 5 were the next most acceptable.
Invitation 4 was significantly more acceptable than all other invitations except 5 and 7
(plus 1), while invitation 5 was significantly more acceptable than all other invitations
except 4, 6 and 7 (plus 1). No other differences between invitations were statistically
significant.
Table 2. Ratings of different screening invitation invitations split by recently and not recently screened










M SE M SE M SE M SE
Invitation 1 6.85 .028b 6.19 .075c 6.69 .043c 6.38 .053d
Invitation 2 5.90 .134a 5.68 .101a 4.85 .151ab 5.05 .104a
Invitation 3 5.84 .139a 5.73 .099a 4.83 .159a 5.06 .107a
Invitation 4 6.03 .129a 5.84 .095ab 5.09 .151ab 5.35 .100c
Invitation 5 6.02 .131a 5.95 .092b 5.11 .151b 5.32 .101bc
Invitation 6 5.87 .139a 5.75 .094a 4.96 .154ab 5.13 .102ab
Invitation 7 5.98 .130a 5.77 .100a 4.97 .153ab 5.20 .102abc
Note. Means in a column that do not share a post-script letter were significantly different from one
another (Bonferroni test, p < .05).
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In relation to how likely respondents would be to use and return a bowel screening kit
in different invitations there were significant effects of invitation, F(6, 2,964) = 3.45,
p = .002, but not gender, F(1, 494) = 2.14, p = .144, age group, F(1, 494) = 0.16, p = .692,
or SES, F(1, 494) = 3.69, p = .055. There was a significant difference by recency of bowel
screening participation, F(1, 494) = 34.24, p < .001with higher ratings of likelihood in the
group who were overdue/never screened. There was also one significant two-way
interaction between invitation and gender, F(6, 2,964) = 4.42, p < .001. Table 3 (left-hand
panel) shows the marginal means and SEs for each invitation split by gender. Post-hoc
Bonferroni tests indicated that in women the only significant differences was between
invitation 1 and 6, with bowel screening kit use perceived to bemore likely in the former.
In men, the only significant difference was between invitation 5 and 6, with bowel
screening kit use perceived to be more likely in the former.
Regarding others’ likelihood to use and return a bowel screening kit in different
invitations, there were significant effects of invitation, F(6, 2,964) = 56.50, p < .001, but
not gender, F(1, 494)= 1.07, p= .302, age group, F(1, 494)= 0.98,p= .324, SES, F(1, 494)=
3.03, p = .082 or recency of bowel screening participation, F(1, 494) = 0.97, p = .324.
There were also significant two-way interactions between invitation and gender, F(6,
2,964) = 2.35, p = .029, invitation and age group, F(6, 2,964) = 2.78, p = .011, and
invitation and recency, F(6, 2,964) = 2.95, p = .007. Table 3 (right-hand panel) shows the
marginal means and SEs for each invitation split by gender, while Table 4 shows the
marginal means and SEs for each invitation split by age and recency. Invitations 3 and 5
were perceived to lead to the highest rates of bowel screening kit use in others by both
women and men. Post-hoc Bonferroni tests indicated that in women invitation 3 and 5
(i.e., £10 voucher) were perceived to lead to significantly higher rates of bowel screening
in others than all other invitations (although the difference between invitation 3 and 7was
not significant). In addition, in women, invitations 1 and 6 were perceived to lead to
significantly lower rates of bowel screening kit use in others than all other invitations.
Post-hoc Bonferroni tests indicated that in men invitations 3, 5, and 7 (i.e., £10 voucher)
were perceived to lead to significantly higher rates of bowel screening kit use in others
than all other invitations. Inmen, invitation 2was perceived to lead to significantly higher
rates of bowel screening kit use in others than invitation 1.
Table 3. Ratings of different screening invitation invitations split by gender for likelihood of ‘self’ and
‘others’ ratings
Likely (self) Likely (others)
Women Men Women Men
M SE M SE M SE M SE
Invitation 1 6.47 .094b 6.44 .089ab 5.15 .071a 5.21 .071a
Invitation 2 6.27 .109ab 6.45 .088ab 5.40 .083b 5.44 .076b
Invitation 3 6.30 .109ab 6.53 .080ab 5.69 .080cd 5.83 .067c
Invitation 4 6.32 .105ab 6.43 .091ab 5.43 .076b 5.38 .076ab
Invitation 5 6.35 .106ab 6.54 .079b 5.75 .078d 5.77 .073c
Invitation 6 6.25 .107a 6.41 .088a 5.20 .083a 5.34 .082ab
Invitation 7 6.32 .107ab 6.54 .079ab 5.55 .084bc 5.72 .074c
Note. Means in a column that do not share a post-script letter were significantly different from one
another (Bonferroni test, p < .05).
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As shown inTable 4 (left-handpanel) therewere anumberof significant differences by
age group. In the younger participants, invitations 3 and 5 were perceived to be likely to
lead to significantly higher rates of screening in others compared to each of the other
invitations, while invitation 7 was perceived to lead to significantly more screening than
invitations 1, 2, 4, and 6. In the older participants, invitation 5 was perceived to lead to
significantly more screening than all other invitations except invitation 3. Invitation 3 and
7were perceived to lead to significantly more screening than invitations 1, 2, 4, and 6, but
were not significantly different from one another.
There were also significant differences by recency of screening Table 4 (right-hand
panel). In up-to-date participants, invitations 3, 5, and 7 were perceived to lead to
significantly more screening than all other invitations. Invitation 2 was perceived to lead
to significantly more screening than invitation 6. In overdue/never screened participants,
invitations 3 and 5were perceived to lead to significantly more screening than invitations
1, 2, 4, and 6 (invitation 3 was also significantly higher than invitation 7). Invitation 1 was
perceived to lead to significantly lower rates of screening in others compared to all other
invitations.
Discussion
The study presented here examined reactions to different financial incentives to
participate inpopulation-level bowel cancer screening in aUK sample The research aimed
to assess the perceived acceptability of the use of incentives to promote bowel screening
in the United Kingdom and explore how these vary by gender, age group, SES group and
recency of screening; along with reactions to specified incentives to promote bowel
screening and the value of incentive judged to be most acceptable.
One of the key requirements of a successful intervention is that it is perceived as
acceptable (Sekhon et al., 2017). In relation to the first research question, whether
incentives for bowel screening are acceptable, abroad range of views were observed,
althoughmost comments (65.3%)were positive or neutral. Negative comments tended to
focus on the idea that individuals should not need to be incentivised to perform bowel
screening. The proportion of positive, negative and neutral responses did not differ by
Table 4. Ratings of different screening invitation invitations split by age or recency of screening for
likelihood ‘others’ ratings






M SE M SE M SE M SE
Invitation 1 5.12 .075a 5.23 .074a 5.31 .080ab 5.06 .066a
Invitation 2 5.43 .076bc 5.40 .082a 5.45 .087b 5.40 .069bc
Invitation 3 5.82 .069e 5.69 .076bc 5.82 .078c 5.70 .065e
Invitation 4 5.49 .070cd 5.32 .081a 5.39 .084ab 5.42 .066bc
Invitation 5 5.77 .074e 5.74 .076c 5.83 .081c 5.69 .065de
Invitation 6 5.28 .078ab 5.26 .086a 5.24 .095a 5.29 .070b
Invitation 7 5.65 .080de 5.60 .078b 5.72 .085c 5.54 .070cd
Note. Means in a column that do not share a post-script letter were significantly different from one
another (Bonferroni test, p < .05).
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gender, age group, or SES group, although they did differ bywhether recently screened. A
greater proportion of respondents overdue for screening reported positive views (52.4%)
compared to up-to-date participants (37.2%). This might support the use of financial
incentives given the focus being on increasing screening rates in those not recently
screened provided it is not off-putting to the recently screened. Despite the suggestion
that providing incentives may raise moral and ethical objections (Lynagh et al., 2013), this
was not strongly supported by the participants in this study. The reasons identified that
might make offering incentives for bowel screening more acceptable varied, although
ensuring unused vouchers could be donated to charity or back to the NHS (9.8%) or
making the voucher easy to use and flexible (9.4%) were the most frequently mentioned.
Some also suggested that highlighting that providing incentives could be cost effective to
the NHS (5.0%) or advertising why the incentive was being offered (9.4%) could improve
the acceptability. Although not a common response in this section, some respondents
(20.2%) emphasised that making the incentive conditional on participating in bowel
screening would be a good idea. As noted earlier such use of conditional financial
incentives might be less appealing from a practical perspective given the need to
additionally identify and then send out incentives to those who complete screening.
The findings also indicated that participants were in favour of research on this topic and
theuse of incentives topromotebowel screening.An incentive voucher of£10valuewas the
most popular stated value (41.3% of respondents), followed by £0 value (23.8% of
respondents), and £5 value (21.6% of respondents). This finding is in line with the study by
Lieberman et al. (2019) that found that a $10 (£7.10) financial incentive, but not a $5
incentive (£3.55), increased FIT screening uptake compared to a non-incentive condition
(82.4% vs. 74.8%).
In relation to the second research question, focussing on reactions to specified
incentives that varied in the monetary value and what happened to the unconditional
incentive, findings were mixed. The current method of invitation was judged to be the
most acceptable to individuals (self) and to others, but this was perceived to be less likely
to encourage screening uptake. Invitationmethods where the NHSwould not be charged
for unused vouchers without the need to return the vouchers (i.e., invitations 4 and 5)
were the nextmost acceptable. However, therewere few significant differences between
invitations in terms ofwhichwasmost likely tomake the individual use and return a bowel
screening kit (Table 3).
Regarding perceptions of others likelihood of using and returning a bowel screening
kit after receiving different invitations, therewere several significant differences (Tables 3
and 4). Invitations with the larger voucher (i.e., £10) were generally perceived to lead to
the greatest participation rates while the current invitation with no voucher was
perceived to lead to the lowest participation rates. There was also some evidence that
being informed that theNHSwould not be charged for unused vouchers (invitations 4 and
5) or that unused vouchers could be returned (invitations 6 and 7) were viewed more
positively. These findings, combined with those on perceived acceptability suggest that
while higher incentives are perceived as more effective, offering no incentive was
perceived as most acceptable. This supports the need to identify and highlight ways of
increasing perceived acceptability of incentives.
One argument against the use of incentives as a behaviour change technique is the
suggestion that they may in fact discourage performance of the behaviour. One study in
consistent non-attenders to diabetic eye screening found that offering a lottery or fixed
cash incentive did not increase attendance and attendance was in fact slightly lower in
these two conditions compared to usual care control (Judah et al., 2018). Based on the
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reactions provided in this study, the proposed offer of incentives in bowel cancer
screening did not support this finding. This research indicates considerable variation in
reactions to using incentives to increase bowel screening rates in the United Kingdom.
Although the majority of individuals are positive or neutral, a sizeable minority are
negative about the use of incentives in this way. A key concern expressed was that
individuals should not need to be incentivised to perform this self-protection measure.
Using relatively modest incentives (up to £10), advertising why incentives are being
offered, explaining the potential cost saving to the NHS, and ensuring the NHS was not
charged if the incentive was not used were stated at factors that might make the use of
incentives more acceptable. These findings, plus the views supporting further research in
this area, would support the idea of using a large-scale RCT to test the effectiveness of
different incentives in a UK sample. Such an RCT might seek to employ relatively modest
incentives (e.g., £5 and £10) compared to the current no incentive invitation and provide
reassurance that unused incentiveswould not be charged to theNHS. The use of shopping
vouchers might be oneway to achieve this provided that voucherswere not charged for if
unused by a specific date. Although some mentioned the idea of incentives being
conditional on participating in bowel screening, this was a small minority and the
additional costs of having to monitor screening and then additionally post out such
conditional vouchers may make such a procedure less appealing.
The reactions to specific incentives were also mixed with the existing method of
invitation (no incentive) being seen as most acceptable to the respondent and to others.
While the existing method of invitation was seen as leading to the highest participation
rates for the self, this invitation was also seen as likely to lead to the lowest rates of
screening in others. Clearly, such perceptions would be best tested in an RCT comparing
the existing no incentivemethodof invitation comparedwith other incentivisedmethods.
Strengths and weaknesses
Strengths of the study include its large sample size and recruitment of individuals from
both areas of greater and lesser deprivation, from across the four nations of the United
Kingdom. However, the majority of the participants were White (98%), which over-
represents this particular ethnic group when compared to the whole of the UK
population. This is a limitation of the study and suggests that the views of ethnic minority
groups on this topic were under-represented in this study. Related to this, the study may
have been influenced by self-sampling bias. However, just over 1/3rd of the sample were
overdue for screening or had never completed screening before, which is around or
slightly higher than the current screening rates in the population.
In conclusion, the current research extends previous research in the United States
(Mehta et al., 2019) on the use of incentives to promote bowel screening attendance in the
United Kingdom. Views on such incentives are clearly mixed although a large majority
favour further research on the potential effectiveness of such incentives in the UK
context. The current findings would support the use of modest incentives (£5 or £10),
emphasis onwhy incentives are being offered, and ensuring that theNHSwas not charged
for unused vouchers. However, effects on actual bowel screening participation rates in
the United Kingdom, using a strong design (e.g., RCT), need to be assessed.
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